ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors
Targeting final lead therapy selection, neutralizing all known previous and current SARS-CoV2 variants of concern by end 2022Triple mode of...

 
           
           
           
          /cloudfront-us-east-2.images.arcpublishing.com/reuters/3EFGPYWEXJPJ7PZZLSBHDZL6RA.jpg) 
           
           
           
          